ID24219A - Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik - Google Patents

Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik

Info

Publication number
ID24219A
ID24219A IDW20000029A ID20000029A ID24219A ID 24219 A ID24219 A ID 24219A ID W20000029 A IDW20000029 A ID W20000029A ID 20000029 A ID20000029 A ID 20000029A ID 24219 A ID24219 A ID 24219A
Authority
ID
Indonesia
Prior art keywords
füä1
ethylü
dibenzoäb
hydroxyethoxy
piperazinyl
Prior art date
Application number
IDW20000029A
Other languages
English (en)
Indonesian (id)
Inventor
Evan William Snape
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of ID24219A publication Critical patent/ID24219A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Liquid Crystal Substances (AREA)
IDW20000029A 1997-08-01 1998-07-28 Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik ID24219A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9716161.6A GB9716161D0 (en) 1997-08-01 1997-08-01 Process

Publications (1)

Publication Number Publication Date
ID24219A true ID24219A (id) 2000-07-13

Family

ID=10816746

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000029A ID24219A (id) 1997-08-01 1998-07-28 Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik

Country Status (32)

Country Link
US (2) US6372734B1 (fr)
EP (2) EP1000043B1 (fr)
JP (2) JP2001512109A (fr)
KR (1) KR20010022241A (fr)
CN (1) CN1125058C (fr)
AT (2) ATE444959T1 (fr)
AU (1) AU739255B2 (fr)
BG (1) BG64796B1 (fr)
BR (1) BR9811061A (fr)
CA (1) CA2295792C (fr)
CY (2) CY2200162T2 (fr)
CZ (1) CZ299225B6 (fr)
DE (4) DE05011169T1 (fr)
EE (1) EE04550B1 (fr)
ES (2) ES2296568T3 (fr)
GB (2) GB9716161D0 (fr)
HK (2) HK1029992A1 (fr)
HU (1) HU228620B1 (fr)
ID (1) ID24219A (fr)
IL (1) IL133618A (fr)
MY (1) MY120999A (fr)
NO (1) NO20000484L (fr)
NZ (1) NZ501914A (fr)
PL (1) PL338384A1 (fr)
PT (2) PT1000043E (fr)
RU (1) RU2224754C2 (fr)
SI (2) SI1000043T1 (fr)
SK (1) SK287145B6 (fr)
TR (1) TR200000848T2 (fr)
TW (1) TW533207B (fr)
WO (1) WO1999006381A1 (fr)
ZA (1) ZA986904B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030216376A1 (en) * 2002-03-20 2003-11-20 Revital Lifshitz-Liron Crystalline forms of quetiapine hemifumarate
US7071331B2 (en) 2003-02-22 2006-07-04 Teva Pharmaceutical Industries Ltd. Synthesis of quetiapine and pharmaceutically acceptable salts thereof
AU2003216705A1 (en) * 2003-03-03 2004-09-28 Hetero Drugs Limited Novel polymorphs of quetiapine fumarate
WO2004089957A1 (fr) * 2003-04-07 2004-10-21 Hetero Drugs Limited Nouvelle forme cristalline de chlorhydrate de dorzolamide
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
WO2006035293A1 (fr) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Formes polymorphiques d'hemifumarate de quetiapine
WO2006056772A2 (fr) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Composes pharmaceutiques
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
CA2603795A1 (fr) 2005-04-14 2006-10-26 Teva Pharmaceutical Industries Ltd. Processus de preparation de fumarate de quetiapine
US20070072840A1 (en) * 2005-05-30 2007-03-29 Pandya Bhargav Polymorphic forms of quetiapine
US8044038B2 (en) * 2005-09-30 2011-10-25 Fermion Oy Crystallization process of quetiapine hemifumarate
EP1948628A1 (fr) * 2005-10-28 2008-07-30 Fermion Oy Purification d hemifumarate de quetiapine par cristallisation
JP2009516706A (ja) * 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 結晶形
US8389510B2 (en) * 2005-11-18 2013-03-05 Astrazeneca Ab Crystalline forms
EP1951258A4 (fr) * 2005-11-18 2013-01-02 Astrazeneca Ab Formulations liquides
CN101360725B (zh) * 2005-11-18 2011-09-21 阿斯利康公司 固体制剂
EP1951694A4 (fr) * 2005-11-18 2010-09-22 Astrazeneca Ab Formes de sels
CZ300451B6 (cs) * 2006-07-03 2009-05-20 Farmak, A. S. Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (fr) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dérivés de dibenzodiazépine
PT1958617E (pt) 2007-02-14 2010-10-28 Lesvi Laboratorios Sl Composições farmacêuticas contendo fumarato de quetiapina
EP2144892A2 (fr) * 2007-03-29 2010-01-20 Teva Pharmaceutical Industries Ltd. Procédé amélioré de préparation de fumarate de quétiapine
WO2009004480A2 (fr) * 2007-05-07 2009-01-08 Actavis Group Ptc Ehf Sels de quétiapine et leurs polymorphes
US20090082334A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched quetiapine
CA2706903C (fr) * 2007-12-05 2015-11-17 Henricus Jacobus Maria Gijsen Agonistes de trpa1 dibenzoazepines et dibenzooxazepines
EP2262486B1 (fr) 2008-08-01 2013-01-02 KRKA, Tovarna Zdravil, D.D., Novo Mesto Composition de quétiapine
WO2010033270A1 (fr) * 2008-09-17 2010-03-25 Auspex Pharmaceuticals, Inc. Modulateurs dibenzothiazepines des recepteurs de la dopamine, alpha-adrenergiques et de la serotonine
EP2403841A1 (fr) 2009-03-04 2012-01-11 Ranbaxy Laboratories Limited Procede de preparation de fumarate de quetiapine
EP2742152B1 (fr) 2011-08-12 2017-04-12 Qiagen GmbH Procédé d'isolation d'acides nucléiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound

Also Published As

Publication number Publication date
NZ501914A (en) 2001-09-28
CA2295792A1 (fr) 1999-02-11
NO20000484D0 (no) 2000-01-31
SI1000043T1 (sl) 2010-01-29
GB9814882D0 (en) 1998-09-09
SK287145B6 (sk) 2010-01-07
NO20000484L (no) 2000-03-16
ES2296568T3 (es) 2011-05-06
TW533207B (en) 2003-05-21
HK1081962A1 (en) 2006-05-26
EE200000062A (et) 2000-10-16
AU739255B2 (en) 2001-10-04
SI1589008T1 (sl) 2011-04-29
ATE444959T1 (de) 2009-10-15
PT1000043E (pt) 2009-11-30
KR20010022241A (ko) 2001-03-15
DE69842104D1 (de) 2011-03-03
ZA986904B (en) 1999-02-01
BG104176A (en) 2000-08-31
CY2200161T2 (el) 2010-07-28
JP2009102345A (ja) 2009-05-14
BR9811061A (pt) 2000-09-19
EP1000043B1 (fr) 2009-10-07
CA2295792C (fr) 2007-04-17
AU8549898A (en) 1999-02-22
EP1000043A1 (fr) 2000-05-17
ES2296575T3 (es) 2010-02-05
SK1302000A3 (en) 2000-06-12
CZ2000341A3 (cs) 2000-05-17
PL338384A1 (en) 2000-10-23
HUP0002663A3 (en) 2001-10-29
EE04550B1 (et) 2005-10-17
ATE496037T1 (de) 2011-02-15
US20020147186A1 (en) 2002-10-10
CN1265101A (zh) 2000-08-30
BG64796B1 (bg) 2006-04-28
HUP0002663A2 (hu) 2001-09-28
RU2224754C2 (ru) 2004-02-27
EP1589008B1 (fr) 2011-01-19
DE05011169T1 (de) 2008-11-06
TR200000848T2 (tr) 2000-08-21
CN1125058C (zh) 2003-10-22
DE98936529T1 (de) 2008-11-20
US6372734B1 (en) 2002-04-16
MY120999A (en) 2005-12-30
WO1999006381A1 (fr) 1999-02-11
ES2296568T1 (es) 2008-05-01
DE69841216D1 (de) 2009-11-19
HU228620B1 (en) 2013-04-29
IL133618A (en) 2004-02-08
IL133618A0 (en) 2001-04-30
CZ299225B6 (cs) 2008-05-21
HK1029992A1 (en) 2001-04-20
CY2200162T2 (el) 2010-07-28
JP2001512109A (ja) 2001-08-21
GB9716161D0 (en) 1997-10-08
ES2296575T1 (es) 2008-05-01
PT1589008E (pt) 2011-03-23
EP1589008A1 (fr) 2005-10-26

Similar Documents

Publication Publication Date Title
ID24219A (id) Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik
CO5200832A1 (es) Derivados de acidos heterociclicos, o una sal farmaceuticamente aceptable de los mismos, que son agentes antidiabeticos y antiobesidad
DE69718835D1 (de) Verfahren zur Herstellung von (N-Phenylacetyl-N-2,6-xylyl)methyl Alaninat
RU93005051A (ru) Способ получения катионных кристаллов гр или производных гр, катионные кристаллы человеческого гр или производных человеческого гр, фармацевтические препараты, использование процесса кристаллизации
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
DE69123025D1 (de) Verfahren zur Herstellung von optisch aktiven Gamma-butyrolactonderivaten
DE68924373D1 (de) Verfahren zur Herstellung konzentrierter Granulatkörner von oberflächenaktiven Mitteln.
DE69813053D1 (de) Verfahren zur Herstellung von optisch aktiven Azetidin-2-Carbonsäurederivaten
DE69321304D1 (de) Verfahren zur Herstellung von optisch aktivem 4-Methyl-2-oxetanon
DE60036758D1 (de) Verfahren zur Herstellung von optisch aktiver 3,3,3-Trifluor-2-hydroxy-2-methylpropionsäure und deren Salze
DE69410222D1 (de) Verfahren zur Herstellung von optisch aktiven Erythro-3-amino-1,2-epoxy-Verbindungen
ID18099A (id) Susunan tombol tangki siram ganda
FI971891A0 (fi) Säätölaite aluksen pääenergialähteen tuottaman energian optimaalisen käytön saavuttamiseksi
AU638829B2 (en) Composition for disinfecting water by the electrochlorination process and use of this composition
DE69200795D1 (de) Verfahren zur Herstellung von L-Prolinederivaten.
DE69825325D1 (de) Verfahren zur Herstellung von 3,3',5,5'-Tetra-t-Butylbiphenol
DE69500362D1 (de) Verfahren zur Herstellung 5,6-dihydroxyindol-Derivate ausgehend von Dopa
DE69127219D1 (de) Verfahren zur Herstellung von optisch aktiven Alkyl-3-aryl-3-hydroxypropionaten
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
DE59812729D1 (de) Verfahren zur Herstellung von 1,3-Dioxanverbindungen
ITRM940832A0 (it) "cerotto per assorbimento transcutaneo a rilascio controllato di fitoassociazione"
SE9602476D0 (sv) Process for the preparation of organic salts of N'N -diacetylcystine
SE9602418D0 (sv) Process for the preparation of organic salts of N'N-diacetylcystine
ITRM940836A0 (it) "cerotto per assorbimento transcutaneo a rilascio controllato di fitoassociazione eventualmente arricchita"
RU97102180A (ru) Гомеопатическое лекарственное средство, обладающее спазмолитической активностью "спазминал-arn"